Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average, structural decline.
Left:
||||
Year-over-year earnings per share growth rate
Latest
10.39%
↓ 73% below average
Average (9y)
39.13%
Historical baseline
Range
High:134.00%
Low:-46.98%
CAGR
-20.7%
Structural decline
| Period | Value |
|---|---|
| 2024 | 10.39% |
| 2023 | -8.54% |
| 2022 | -46.98% |
| 2021 | 134.00% |
| 2020 | 68.47% |
| 2019 | -8.97% |
| 2018 | 88.91% |
| 2017 | 31.81% |
| 2016 | 38.57% |
| 2015 | 83.63% |